Dr Reddys Laboratories RDY
NYSE RDY
$12.85 +0.34 (+2.68%)
As of: Sep 29, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Share-based Compensation (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) recorded Share-based Compensation of $1.02 million in the quarter ended Jun 30, 2026, down 21.7% from $1.31 million a year earlier.

Analysis

Dr Reddys Laboratories (RDY) Share-based Compensation (2009 - 2026) Analysis & Trends

On a TTM basis, Dr Reddys Laboratories' Share-based Compensation came in at $4.76 million as of Jun 30, 2026, down 4.2% year-over-year; for the year ended Mar 31, 2026, it was $3 million, down 40.0% from the prior year.

  • Annual Share-based Compensation has a five-year compound annual growth rate of -17.8% (years ended Mar 2021 to Mar 2026).
  • Across earlier years, Share-based Compensation came in at $5 million in the year ended Mar 31, 2025 (unchanged), $5 million in the year ended Mar 31, 2024 (unchanged), $5 million in the year ended Mar 31, 2023 (-37.5%) and $8 million in the year ended Mar 31, 2022 (unchanged).
  • The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Share-based Compensation since the quarter ended Mar 31, 2023.
  • On a year-over-year basis, Share-based Compensation rose in two of the last four quarters, with an average decline of 5.3%.
  • Peak year-over-year performance for Share-based Compensation in the last five years was growth of 357.2% in the quarter ended Mar 31, 2024, against a decline of 86.4% in the quarter ended Mar 31, 2023 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Dr Reddys Laboratories 10.44 Bn 9.62 Bn 396.53 Mn 1.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.02 Mn
Sep 30, 2025 1.15 Mn
Jun 30, 2025 1.31 Mn
Sep 30, 2024 1.28 Mn
Jun 30, 2024 1.21 Mn
Mar 31, 2024 1.17 Mn
Dec 31, 2023 1.19 Mn
Sep 30, 2023 1.25 Mn
Jun 30, 2023 1.31 Mn
Mar 31, 2023 255,461.90
Dec 31, 2022 1.38 Mn
Sep 30, 2022 1.47 Mn
Jun 30, 2022 1.89 Mn
Mar 31, 2022 1.88 Mn
Dec 31, 2021 2.15 Mn
Sep 30, 2021 1.93 Mn
Jun 30, 2021 1.99 Mn
Mar 31, 2021 1.77 Mn
Dec 31, 2020 2.04 Mn
Sep 30, 2020 2.16 Mn
API Access

Dr Reddys Laboratories Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RDY&period=max&api_key=YOUR_API_KEY